The 2024 PM360 Pharma Choice Awards – Multichannel Silver Winner

Luminous Creative Imaging, Ogilvy Health, and Ferring Pharmaceuticals Inc.

Bugs of Paradise

The REBYOTA campaign features a juxtaposition of the desolate barrens and lush flora. The imagery symbolizes the impact of delivering diverse bacteria direct to the gut microbiome with REBYOTA to prevent the recurrence of C. difficile infection and restore hope to patients—delivered in a strategic and innovative channel mix.

FERRING PHARMACEUTICALS TEAM MEMBERS:
David Bell Commercialization Lead – Microbiome
Jennifer Accumanno Director, HCP Marketing – Microbiome and GI
Christina Cirasuolo Senior Manager, HCP Marketing – Microbiome
Ashley Villani Manger, Marketing – Microbiome

OGILVY HEALTH TEAM MEMBERS:
Deborah Ciauro Executive Creative Director
George Giunta VP, Group Creative Director
Lori Lagitch Associate Creative Director
Mike Brune Executive Creative Director
Bryan Minogue Associate Creative Director
Julieta Smith SVP, Planner
Julia Weiss Director, UX & Content Strategy
Laura Schember Client Engagement Officer
Avery (Riggs) Stephens Senior Account Executive
Beth Lamlamay VP, Director of Project Management

Ads

You May Also Like

TechKNOW: We Tip Our Smart Hat to These Next-Gen Wearables

This year’s crop of wearable technology is here to, if you’ll excuse my horrible ...

2019 Pharma Choice Multicultural Bronze Winner EMCAY and Amgen Inc.

EMCAY Amgen Inc. Multiple Myeloma It’s On Multiple myeloma is the second most common ...